Farshad Guirakhoo - 10 Nov 2021 Form 3 Insider Report for Vaxxinity, Inc. (VAXX)

Role
Chief Scientific Officer
Signature
/s/ Rene Paula, attorney-in-fact for Farshad Guirakhoo
Issuer symbol
VAXX
Transactions as of
10 Nov 2021
Net transactions value
$0
Form type
3
Filing time
10 Nov 2021, 15:58:24 UTC
Next filing
15 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VAXX Stock option (right to buy) 10 Nov 2021 Class A common stock 126,730 $0.5681 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 126,730 time-vesting options. These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period.

Remarks:

Exhibit 24 - Power of Attorney